UA100403U - METHOD OF PREVENTION OF DIABETES MELLITUS AND ITS COMPLICATIONS - Google Patents
METHOD OF PREVENTION OF DIABETES MELLITUS AND ITS COMPLICATIONSInfo
- Publication number
- UA100403U UA100403U UAU201500684U UAU201500684U UA100403U UA 100403 U UA100403 U UA 100403U UA U201500684 U UAU201500684 U UA U201500684U UA U201500684 U UAU201500684 U UA U201500684U UA 100403 U UA100403 U UA 100403U
- Authority
- UA
- Ukraine
- Prior art keywords
- complications
- prevention
- diabetes mellitus
- diabetes
- inhibitor
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- QYPPJABKJHAVHS-UHFFFAOYSA-N Agmatine Natural products NCCCCNC(N)=N QYPPJABKJHAVHS-UHFFFAOYSA-N 0.000 abstract 1
- QYPPJABKJHAVHS-UHFFFAOYSA-P agmatinium(2+) Chemical compound NC(=[NH2+])NCCCC[NH3+] QYPPJABKJHAVHS-UHFFFAOYSA-P 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Спосіб профілактики цукрового діабету та його ускладнень, в якому внутрішньом'язово вводять інгібітор синтезу NO. Як інгібітор використовують агматин у концентрації 20 мг/кг, при цьому його вводять одноразово щоденно протягом 14 днів.Method for the prevention of diabetes and its complications, wherein the NO synthesis inhibitor is administered intramuscularly. As an inhibitor used agmatine at a concentration of 20 mg / kg, while it is administered once daily for 14 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201500684U UA100403U (en) | 2015-01-28 | 2015-01-28 | METHOD OF PREVENTION OF DIABETES MELLITUS AND ITS COMPLICATIONS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201500684U UA100403U (en) | 2015-01-28 | 2015-01-28 | METHOD OF PREVENTION OF DIABETES MELLITUS AND ITS COMPLICATIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA100403U true UA100403U (en) | 2015-07-27 |
Family
ID=53721367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201500684U UA100403U (en) | 2015-01-28 | 2015-01-28 | METHOD OF PREVENTION OF DIABETES MELLITUS AND ITS COMPLICATIONS |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA100403U (en) |
-
2015
- 2015-01-28 UA UAU201500684U patent/UA100403U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ766978A (en) | Atr inhibitor and application thereof | |
| ZA201701299B (en) | Glycosidase inhibitors | |
| PH12015502031A1 (en) | Tetrahydropyrrolothiazine compounds | |
| PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| EA201890899A1 (en) | PHARNESIDE X-RECEPTOR MODULATORS | |
| MX2018010192A (en) | Glycosidase inhibitors. | |
| MY197698A (en) | Oxysterols and methods of use thereof | |
| EP4609866A3 (en) | Oxysterols and methods of use thereof | |
| EA201591805A1 (en) | OXABICICLO [2.2.2] ACIDS - MODULATORS GPR120 | |
| SG10201804026WA (en) | Inhibitors of influenza viruses replication | |
| NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
| NZ718373A (en) | Substituted piperidyl-ethyl-pyrimidine as ghrelin o-acyl transferase inhibitor | |
| WO2018153508A3 (en) | Sulfoximine glycosidase inhibitors | |
| EA201790726A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS | |
| PH12018500377A1 (en) | Novel annelated benzamides | |
| MX2020006436A (en) | Mtor inhibitor compounds. | |
| MX2020006434A (en) | Novel mtor inhibitor compounds. | |
| PH12018500378A1 (en) | Novel annelated phenoxyacetamides | |
| MX2017006709A (en) | Agent for preventing or improving symptoms caused by imbalance of sex hormones. | |
| MY198008A (en) | Crystal of benzofuran derivative free base and preparation method | |
| EA201692270A1 (en) | DERIVATIVES OF NAFTYRIDINDIONE | |
| UA115583C2 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| TN2019000038A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
| MY193239A (en) | Novel b-lactamase inhibitors | |
| NZ755298A (en) | Pyrrolotriazine derivatives as kinase inhibitor |